title: Peripheral vascular complications after intracoronary stent placement: prevention by use of a pneumatic vascular compression device.
abstract: Peripheral vascular complications are a significant source of morbidity after coronary artery stent implantation. The goal of this study was to assess the incidence, risk factors, and management of vascular complications after stent placement. The study population consisted of 101 consecutive patients who underwent stent placement for either elective or bailout indications. All patients received a standardized anticoagulation regimen of aspirin, dipyridamole, low molecular weight dextran, heparin, and warfarin. Peripheral vascular access sites were examined daily until hospital discharge. Vascular complications occurred in 16 of 101 (16%) patients, including femoral artery pseudoaneurysm (n = 11), hematoma requiring transfusion or surgery (n = 4), and arteriovenous fistula (n = 1). Intervention was required in 14 of 16 (88%) patients with complications. These included transfusion (n = 7), ultrasound-guided compression (n = 8), and/or vascular surgery (n = 7). Length of hospital stay was prolonged in patients with complications (14 +/- 9 vs. 8 +/- 5 d, P < 0.001). The development of peripheral vascular complications did not correlate with clinical or procedural variables such as age, cardiovascular risk factors, arterial sheath size, or elective vs. bailout indication. After the introduction of a pneumatic vascular compression device (FEMOSTOP, C.A. Bard, Billerica, MA), a significant reduction in vascular complications was observed. Complications occurred in only 1 of 41 (2.4%) patients in whom the compression device was used in contrast to 13 of 58 (22.4%) patients compressed manually (P < 0.01). Thus peripheral vascular complications are frequent after coronary artery stent placement and are associated with serious morbidity and prolongation of hospital stay. These complications are significantly reduced by the use of a pneumatic vascular compression device despite intensive systemic anticoagulation.
authors.affiliation: Division of Cardiology, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.
authors.forename: K
authors.initials: K
authors.lastname: Sridhar
authors.forename: D
authors.initials: D
authors.lastname: Fischman
authors.forename: S
authors.initials: S
authors.lastname: Goldberg
authors.forename: A
authors.initials: A
authors.lastname: Zalewski
authors.forename: P
authors.initials: P
authors.lastname: Walinsky
authors.forename: D
authors.initials: D
authors.lastname: Porter
authors.forename: S
authors.initials: S
authors.lastname: Fenton
authors.forename: B
authors.initials: B
authors.lastname: Gupta
authors.forename: R
authors.initials: R
authors.lastname: Rake
authors.forename: S
authors.initials: S
authors.lastname: Gebhardt
authors.forename: M
authors.initials: M
authors.lastname: Savage
mesh_terms: D006488:Hemostasis, Surgical / Q000295:instrumentation*; D006801:Humans; D007902:Length of Stay; D016491:Peripheral Vascular Diseases / Q000209:etiology* / Q000517:prevention & control; D011183:Postoperative Complications; D011312:Pressure; D015607:Stents